At the recent SEC meeting for endocrinology and metabolism, the expert panel reviewed the proposal along with the ...

The decision comes after evidence suggested these drugs protect the heart and kidneys as well as controlling blood sugar, ...

New draft guidance from the National Institute for Health and Care Excellence suggests the NHS should move away from a ...

The study tested the effects of balcinrenone/dapagliflozin, a drug combination, both in fed and fasted states, and with the addition of quinidine, a P-gp inhibitor. The purpose is to understand how ...

Today’s announcement (August 20) on draft guidelines from the UK’s National Institute for Health and Care Excellence (NICE) ...

The change from the National Institute for Health and Care Excellence will be the most significant for a decade ...

The NHS should move away from a one-size-fits-all approach of starting everyone on the same medication, to more personalised care that aims to prevent complications like heart failure and heart ...

GPs could face a rise in prescribing and monitoring work under draft NICE guidelines recommending earlier use of newer type 2 ...

AstraZeneca has revealed plans to set up a new strategic R&D hub in Cambridge, Massachusetts as it reported a massive increase in first-quarter revenues, driven by COVID-19 and oncology drugs and ...

The new label for Forxiga/Farxiga (dapagliflozin) comes from the DECLARE-TIMI 58 trial, and the EU is the first major market to approve the label update, ahead of the US and China where it remains ...